Skip to main content
From complexity to compliance

Assisting UCB to manage its environmental obligations

UCB

UCB collaborates with Deloitte to navigate new packaging legislation. Through a dynamic NZYME workshop, experts of both companies have merged their thinking to envision sustainable solutions and foster a co-creative approach to the circular economy.

UCB is a global biopharmaceutical company dedicated to improving the lives of people living with severe illness. Compliance is critical for the company’s operations. This applies to medical requirements, but also to other aspects such as environmental obligations.

In the wake of preparing for the operationalisation of new packaging legislation, UCB and Deloitte put their heads together and through merging the collective strengths of our teams in tax, supply chain, strategy & analytics, and SAP, we organised a half-day “Humble & Proud” session. Using Deloitte’s new Nzyme methodology, which amalgamates deep industry knowledge with the right interpersonal dynamics, the teams shared insights on packaging fees and plastic taxes. Our team brainstormed with the 15 UCB participants on how to best set up the company for success. 

The interactive nature of the Nzyme methodology generated a high energy workshop with a great co-creation dynamic around sustainability and the circular economy. The passion from the Deloitte and UCB team combined with strong facilitation helped the teams to get a full view on the challenges in different departments and to envisage transversal solutions. 

“Collaborating with UCB on navigating new packaging legislation has been both inspiring and rewarding. Together, we're forging innovative solutions that not only ensure compliance but also contribute to a more sustainable future.”

Maarten Dubois, Director, Sustainability & Circular Economy at Deloitte

The interactive nature of the Nzyme methodology generated a high energy workshop with a great co-creation dynamic around sustainability and the circular economy.

About UCB

UCB is a global biopharmaceutical company dedicated to improving the lives of people living with severe illnesses. They focus on developing and providing innovative treatments and therapies to address unmet medical needs in various therapeutic areas, including neurology, immunology, and bone health.

Key contacts

Maarten Dubois

Director | Consulting | Sustainability & Circular Economy